Ildong Pharmaceutical advances into the Chinese market for raw materials for hypertension treatment

COMPANY / Reporter Kim Jisun / 2023-08-23 01:46:30
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Ildong Pharmaceutical Co. said on the 22nd that it has decided to export its cardiovascular raw material drug (API) Benidine Hydrochloride’ to Guangzhou Tosun Pharmaceutical in Guangzhou, China.

Benidipine is a calcium channel blocker (CCB) that expands blood vessels and relieves the burden on the heart by blocking the passage of calcium ions involved in the contraction of blood vessels and heart muscles, and is mainly used to treat high blood pressure and angina.

The company said it has recently signed a contract on a partnership between the two companies, including Tosun and Benidipine supply, and is carrying out all the necessary procedures to advance into China. Ildong Pharmaceutical had previously obtained registration and approval of raw materials for Benidipine from Chinese drug management authorities.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Doosan Secures KRW 947.7 Billion by Selling Stake in Doosan Robotics Ahead of SK Siltron Acquisition
[Exclusive] Major Power Outage at SK Ecoplant Yongin Semiconductor Site…“Now Fully Restored”
Mirae Asset Stocks Diverge on SpaceX IPO Expectations
Special Prosecutors Launch Raid on Coupang Over Alleged Severance Pay Mismanagement
Samsung Heavy Industries Apologizes for Fatal Accident at Geoje Shipyard
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS